What to Know Before Buying CBD

TESTSTSARDSAR

What to Know Before Buying CBD by Ebby Stone

Inflammation causes backaches, menstrual cramps, swollen joints, and many other ailments. That’s why nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen are among the most commonly used drugs in the world.

If you’re trying to move away from reliance on NSAIDs, cannabidiol (CBD) can be an effective alternative. Before jumping aboard the CBD train, there are a few key considerations.

Quality Assurance

CBD is available in virtually every gas station and corner store. But not all products are equal. Look for certified organic products. These are grown without pesticides and contain fewer toxins that may aggravate inflammation.

Want More Like This? Read the latest issue of Cannabis & Tech Today.

Search the packaging for a certificate of analysis QR code. Quality products are potent, pure, and shelf stable — with test results to prove it. Reputable companies make it easy to find test results. If you don’t see it on the packaging, you may find test results on the company’s website.

If not, it’s best to keep searching for a more transparent company. Tests should include the CBD to THC ratio, potency per milligram, and information about mold and mildew as well as the presence of heavy metals.

Dosage

“Start low and go slow” is an apt mantra for most cannabis products. But, many people don’t feel relief from non-THC CBD until nearing the same milligram dose as what is available from over-the-counter medications like ibuprofen.

Many NSAIDs contain at least 200mg per tablet. Conversely, many CBD products are available in small doses, like 5mg per capsule. You can start low, but feel free to increase your dosage until you notice a pain-relieving effect. 

Ingestion Method

One incredible benefit of legalization is product diversity. You can find CBD in practically any form. Tinctures are an excellent option for obtaining rapid relief with higher doses.

There are loads of CBD gummies available, but they are sugary and may contain animal byproducts like gelatin. Gel capsules are an excellent alternative to gummies as they have no taste and can be quickly scaled to the appropriate dose.

Join Our Mailing List

A transdermal patch can also be a quick, effective delivery method that offers prolonged pain relief. Similarly, salves and creams can target the source of the irritation with a quick onset.

Pain-Free With CBD

You may hear people say CBD is only effective for mild pain. In this author’s experience, a higher dose is necessary for adequate pain relief.

Find a delivery format that works for your lifestyle and preferences. A transdermal patch is discreet and continuous for a day at the office. Gel capsules offer a familiar “medicine cabinet” approach to relief. And tinctures are helpful for any occasion when seeking faster effects.

While the milligrams per dose and the preferred delivery method will be different for everyone, the necessity of a pure, quality-tested product is universal. Do your diligence and before you know it, you could be leaving NSAIDs on the shelf and opting for a liver-friendly CBD alternative.

This article first appeared in Volume 4 Issue 4 of Cannabis & Tech Today. Read the full issue here.

A link to your site, with your site's name and description as anchor text.

Via https://cannatechtoday.com/what-to-know-before-buying-cbd/

source https://renzverspaget.weebly.com/blog/what-to-know-before-buying-cbd

Zero Hour: ESG Like Your Life Depends On It

TESTSTSARDSAR

Zero Hour: ESG Like Your Life Depends On It by Ebby Stone

Pay attention. Your survival could depend on it. Cannabis consumers, I’m talking to you. How’s the environment looking? Pretty bleak. Is the economy rock steady? Far from it. Let’s not even talk about the quality of global leadership right now. These elements are the foundation of a seemingly abstract term — ESG. It stands for Environmental, Social, and Governance, and it affects the fate of mankind. 

If corporations don’t start taking a hard look at how they’re addressing ESG on a micro scale, it spells disaster on a macro scale.

Join Our Mailing List

Consumers matter here. Money, the money in your pocket right now, tells a story wherever it goes. It describes what you care about and cries out your hope for the future.

When people invest in companies with ESG frameworks, they’re investing in responsibility — in green grass and blue skies. ESG-focused companies are the foundational elements of a tomorrow we can all thrive in. 

As purchasers, you have a voice. As business owners, you have a choice. Companies can decide right now if they want to be part of tomorrow’s economy.

Investing in ESG frameworks tells customers you want to exist in 20 years. It tells investors you’re looking ahead at the regulations sitting in dusty stacks on bureaucrats’ desks across the globe.

These requirements, to do one’s best for the environment, for society, and as leaders, are more than a moral imperative. They’re quickly becoming law.

They’re cementing themselves as the only way to do business. And they’re often the best way to attract customers and investors to one’s business model. 

Want More Like This? Read the latest issue of Cannabis & Tech Today.

Geoff Trotter, a co-founder of ESG and sustainability advisory firm Regennabis, believes companies can create an ESG-centric business model without losing money.

“You can create massive profitability in this space and do good. They’re not mutually exclusive,” Trotter noted during a recent interview with Cannabis & Tech Today. 

Any company looking to live out the capitalist dream of global expansion should also note the demand for ESG is much louder in the international marketplace. America is sort of whispering about it. Other nations are shouting it.

Trotter touched on this point, “If you think you can exist in a vacuum in the United States, you have another big challenge coming if you are aspiring then to operate, for example, in Germany or Europe. Generally, ESG performance is more than expected, it’s now a legal requirement.”

So, whether you’re a business owner or a consumer, spend your dollars thoughtfully. If you’re a buyer, buy with the knowledge that your choices will affect your kids’ lives.

If you’re a business, consider the planet, its people, and your purpose in daily operations. Businesses and the buyers that support them have one thing in common — humanity.

We’re part of the same human race watching the Doomsday Clock ticking down. Let’s set back that clock and make an effort like our lives depend on it.

This article first appeared in Volume 4 Issue 4 of Cannabis & Tech Today. Read the full issue here.

A link to your site, with your site's name and description as anchor text.

Via https://cannatechtoday.com/zero-hour-esg-like-your-life-depends-on-it/

source https://renzverspaget.weebly.com/blog/zero-hour-esg-like-your-life-depends-on-it

Did President Bidens Medical Cannabis Research Act Actually Help Anything?

TESTSTSARDSAR

Did President Biden’s Medical Cannabis Research Act Actually Help Anything? by Sarah Lee Gossett Parrish

A new year encourages hope and reflection, both of which are useful in evaluating existing cannabis policies at the federal level and what may be expected in the coming months.

Significantly, while the industry suffered a loss in the unsuccessful efforts to include the Secure and Fair Enforcement (SAFE) Banking Act in the National Defense Authorization Act, Congress did pass the first standalone piece of cannabis reform legislation, the Medical Marijuana and Cannabidiol Research Expansion Act (H.R. 8454), which President Biden signed into law on Dec. 2, 2022.

However, the legislation has met with mixed reviews among industry professionals, and whether it ultimately benefits medical cannabis research endeavors or serves as an impediment to them remains to be seen.  

How Will H.R. 8454 Change Cannabis Research?

The bipartisan Medical Marijuana and Cannabidiol Research Expansion Act (H.R. 8454)  eases federal restrictions on scientific research by streamlining the application process for approval of cannabis-related studies and simplifies requests for large quantities of cannabis for such studies.

Currently, the United States Drug Enforcement Administration (DEA) reviews and licenses marijuana cultivators and grants Schedule I licenses to scientists seeking to study cannabis in clinical environments.

The act changes this process by mandating that the United States Attorney General solicit cannabis cultivation applications for research or potential drug development purposes, and imposes a 60-day deadline for approval of research applications.

Join Our Mailing List

Theoretically, these changes will eliminate the DEA’s current lag times for approval of research protocols advanced by scientists working with cannabis, which have been known to drag on for years.  

Additionally, the act encourages the Food and Drug Administration to support cannabis-derived medications and requires federal agencies to provide a report concerning the “potential therapeutic effects of cannabidiol or marijuana on serious medical conditions.”

The act also directs the Department of Health and Human Services to work with the National Institutes of Health to analyze the therapeutic effects of cannabis for epilepsy and other conditions.

Further, it will study how cannabis affects adolescent brain development, how it may impact the ability to operate motor vehicles, and  determine how to overcome barriers that currently exist which inhibit cannabis research.

Who Grows the Research Crops?

One notable barrier to scientific research concerning the therapeutic benefits of cannabis that has existed for many years arises from current restrictions on the set of federally licensed cannabis cultivators.

At present, this pool is limited to the University of Mississippi, which was granted a federal cannabis cultivation license in 1968.

_{All U.S. government research on cannabis relies on supplies from a subpar source.}

Unfortunately, the university has historically produced low-quality cannabis for research purposes, and the product’s inferiority arguably has caused significant distortion in the results yielded from research projects utilizing such cannabis. 

While the DEA expressed its intention to expand the pool of growers beyond the University of Mississippi in 2016, expansion progress has moved at a glacial pace.

Five years passed before the DEA announced in May 2021 that it had approved several third-party cultivation applicants to grow cannabis for use in federally approved clinical trials. To date, no notable advances have been reported in that regard. 

Cannabis Science Relies on Quality Samples

It is undisputed that the quality of cannabis available for scientific research is of paramount importance.

The language that would allow researchers to conduct studies on cannabis currently sold in state-legal markets, thereby aligning the quality of cannabis utilized in human clinical trials with the cannabis currently consumed by patients and adult consumers in state-legal markets, was removed before the act’s passage by the Senate. 

Paul Armentano, deputy director of the National  Organization for the Reform of Marijuana Laws, criticized this omission, opining that “[w]hile the  Expansion Act is a step in the right direction, the limited variety of cannabis cultivars accessible to federally licensed researchers does not represent the type or quality of cannabis products currently available in legal, statewide markets … The fact that nearly one-half of U.S. adults have legal access to these multitudes of cannabis products, but our nation’s top scientists do not, is the  height of absurdity and highlights the need for continued legislative action if we want to more  easily study the state-legal products that millions of Americans are actually using.”

A Counterproductive Nightmare?

Armentano’s astute observation highlights the disconnect that exists between current federal cannabis policies and the cannabis policies adopted by states with medical and adult use legal markets.

_{Cannabis reform continues to be a lengthy process mired in red tape.}

Oregon Democratic Representative Earl Blumenauer, co-sponsor of the legislation in the House with Maryland Republican Representative Andy Harris, commented in a statement that “[a]s we have seen in state after state, the public is tired of waiting for the federal government to catch up. More than 155 million Americans — nearly half of our nation’s population — now  reside in states where adult use of cannabis is legal.” 

Indeed, Blumenauer, founder and co-chair of the Congressional Cannabis Caucus, has worked on cannabis reform for decades.

He further observed in his statement addressing the act’s passage, “finally the dam is starting to break. The passage of my Medical Marijuana and Cannabidiol Research Expansion Act in the House and  Senate represents a[n] historic breakthrough in addressing the federal government’s failed and misguided prohibition of cannabis.”  

Want More Like This? Read the latest issue of Cannabis & Tech Today.

Nonetheless, the legislation is not without its critics, and perhaps for good reasons. Vicente Sederberg attorney Shane Pennington has dubbed it “a counterproductive nightmare,” observing that the Act imposes DEA registration requirements concerning CBD, whereas current law does not require any special DEA registration for CBD research.

In an article titled Turning Water Into Weed And Other Absurdities, Pennington concludes that “[b]y imposing registration requirements on these otherwise-non-controlled substances, this bill dramatically increases barriers to cannabis research.” (Emphasis original).

Shifting Cannabis Policy

Pennington observes that, via the attorney general, the DEA will have “unbridled authority to avoid licensing any marijuana manufacturers at all simply by refusing to place a notice in the federal register seeking more applications.” Currently, the Drug  Enforcement Administration does not have such power over any application. 

Pennington also points out that the legislation provides the DEA with the ability to avoid deadline triggers simply by refusing to accept an application as “complete,” in contrast to current DEA regulations under which the electronic filing system deems all applications received to be automatically complete or sends an error message advising of missing information necessary for resubmission.

Private research concerning the therapeutic benefits of cannabis is coming into its own. Recently, the Wana Brands Foundation, led by founder and chief executive officer Nancy Whiteman, awarded a $3 million grant to Johns Hopkins University to help further medical cannabis research.

It will be interesting to follow the quality of cannabis available and actually utilized for such research, in light of the Medical Marijuana and Cannabidiol Research Expansion Act.

One can only hope that Congress will continue on a trajectory that promotes and encourages significant shifts in federal cannabis policies in this new year. Only time will tell.

This article first appeared in Volume 4 Issue 4 of Cannabis & Tech Today. Read the full issue here.

A link to your site, with your site's name and description as anchor text.

Via https://cannatechtoday.com/did-president-bidens-medical-cannabis-research-act-actually-help-anything/

source https://renzverspaget.weebly.com/blog/did-president-bidens-medical-cannabis-research-act-actually-help-anything

German Legalization Will Spur Innovation in Consumption and Cultivation Technology

TESTSTSARDSAR

German Legalization Will Spur Innovation in Consumption and Cultivation Technology by Johnny Green

Earlier this month federal ministers in Germany conducted a press conference in which they provided details regarding the nation’s adult-use cannabis legalization plan.

Germany’s legalization plan involves permitting personal possession, cultivation, and consumption, and noncommercial cannabis clubs will serve as the initial foundation for access to legal cannabis.

Eventually Germany will also have regional cannabis commerce pilot programs, although many of the details regarding the pilot programs are still up in the air and will be part of a second phase for the legalization plan.

A Looming Home Cultivation Boom

While it is tough to say with exact certainty how many adults in Germany will cultivate their own cannabis for adult-use purposes once it becomes legal, there is relevant data out of Canada that can provide some insight.

Join Our Mailing List

According to a study conducted in Canada in 2022 by researchers associated with a variety of leading institutions, roughly 10% of Canadian cannabis consumers engage in home cultivation.

That statistic, coupled with the estimated cannabis usage rates in Germany (8.8% of the population), works out to several hundreds of thousands of potential legal home cultivators in Germany’s near future.

In addition to home cultivators coming up with, and presumably widely sharing online, their tips and hacks for growing at home, inventors and innovators will no doubt be working around the clock to come up with the next great home cultivation technological breakthrough to bring to market.

Personal Consumption Technology

A ‘perfect storm’ is brewing in Germany right now on the personal consumption technology front, in that the country already serves as the birthplace for one of the greatest cannabis consumption devices of all time – the Volcano.

Additionally, consumers are about to have more access to legal cannabis than ever before, and once noncommercial clubs launch, they will have more places to legally consume cannabis outside of their homes than ever before as well.

_{Could Germany become an epicenter for new cannabis technologies?}

Given Germany’s long history of being one of the most technologically innovative countries on earth, it’s likely a safe bet that there will be new industry-disrupting consumption gadgets coming out of Germany in the coming years.

Learn More At ICBC Berlin

The International Cannabis Business Conference’s (ICBC) flagship event is coming back to Berlin on June 29-30^th. 

See the latest cannabis science and technology that will be on full display at the conference. The ICBC in Berlin is Europe’s largest cannabis B2B event and tradeshow.

Cannabis leaders from over 80 countries will be in attendance and with so much going on in Germany right now, the conference is a must-attend for anyone who is serious about succeeding in Germany’s industry, as well as those wishing to succeed at the continental and international levels. 

Purchase your tickets today before the event sells out!

A link to your site, with your site's name and description as anchor text.

Via https://cannatechtoday.com/german-legalization-will-spur-innovation-in-consumption-and-cultivation-technology/

source https://renzverspaget.weebly.com/blog/german-legalization-will-spur-innovation-in-consumption-and-cultivation-technology

How Can Cannabis Help Our Furry Friends?

TESTSTSARDSAR

How Can Cannabis Help Our Furry Friends? by Rachelle Gordon

The CBD for animals category is exploding, but can cannabis help pets the way it helps people?

“My pet is a member of the family.”

You’ve probably heard this statement before, or even said it yourself. Nearly 70% of American households have a companion animal, with dogs and cats being by far the most popular.

Many pet owners often go to great lengths to ensure their furry friends are happy and healthy, whatever the cost.

Join Our Mailing List

As more people benefit from cannabis, particularly CBD, there’s a growing demand for products formulated for animals.

Scientific research on cannabis and animals remains extremely limited, but anecdotal evidence has revealed a wide range of benefits, from helping to treat separation anxiety to reducing chronic pain, driving an explosion in sales.

_{The CBD for animals category is exploding, but can cannabis help pets the way it helps people?}

The pet CBD category was valued at $629 million in 2021, according to analysis from the Brightfield Group. It’s expected to balloon to over $1 billion by 2025.

The same report showed a significant uptick in the number of animal owners discussing CBD with their veterinarians, with more people than ever wondering: How can cannabis potentially help my pet?

CBD Benefits in Animals Mimics Humans

It’s worth noting that all mammals (not just humans) have an endocannabinoid system, with CBD showing similar benefits for animals as those found in people. And while the majority of research into CBD focuses on what it can do for humans, a few studies have focused on CBD’s potential for pets. 

Findings from a 2018 trial published in the journal Frontiers in Veterinary Science revealed administering CBD twice a day may help ease symptoms in dogs with osteoarthritis.

Want More Like This? Read the latest issue of Cannabis & Tech Today.

A 2019 study published in the National Library of Medicine also centered on canines; it showed CBD decreased seizure activity. Additional studies on dermatitis and anxiety had mixed results, with scientists concluding that CBD shows promise but requires additional testing.

Kurt Kinneman, owner of Bad Apple Pets, said most people seek out his company’s CBD dog treats, equine pellets, and pet tinctures as a way to help their animals relax. 

“The main use case I see is anxiety, whether it’s separation-related or events like vet visits or the Fourth of July,” Kinneman told Cannabis & Tech Today. “Joint conditions and arthritis would be second, followed by itching.”

Kinneman attributes the success of his full-spectrum CBD products to the anti-inflammatory properties of the cannabinoid, noticing that when animals have fewer symptoms, they’re able to feel more at ease overall.

“We like to say ‘calm bodies, calm minds,’” he said.

Anecdotal Evidence Bulk of Veterinarian Knowledge

Word-of-mouth has been a key driver of customer acquisition for Bad Apple Pets, but Kinneman hopes more veterinarians will soon join the conversation.

_{Kinneman attributes the success of his full-spectrum CBD products to the anti-inflammatory properties of the cannabinoid, noticing that when animals have fewer symptoms, they’re able to feel more at ease overall.}

Currently, most veterinarians rely on anecdotal information about CBD for pets gathered from examinations or owner reports.

A recent survey revealed that over half observed CBD being at least somewhat helpful for chronic pain in their patients, and 75% reported the compound was useful for reducing anxiety and seizures. 

Despite the promising results, only 45 % of veterinarians surveyed felt comfortable discussing CBD with their clients.

However, the vast majority supported removing cannabis from Schedule I status and increasing scientific studies.

“We need more research and regulation of the space to help legitimize it,” Kinneman argued. “CBD is already helping a lot of animals, but there are so many more who I believe could really benefit.”

This article first appeared in Volume 4 Issue 4 of Cannabis & Tech Today. Read the full issue here.

A link to your site, with your site's name and description as anchor text.

Via https://cannatechtoday.com/how-can-cannabis-help-our-furry-friends/

source https://renzverspaget.weebly.com/blog/how-can-cannabis-help-our-furry-friends

PlusCBD THC-Free Gummies Review

Welcome to our Plus CBD Daily Balance Gummies review!

At 25 mg of CBD per piece, these THC-free gummies were formulated to mirror the calming and discomfort-relieving effects of full-spectrum hemp as closely as possible.

Extracted safely with CO2 and paired with non-GMO, vegan ingredients, this hemp extract proved effective among our testers, but if you’re used to full-spectrum, you may notice a drop off in potency.

Overall, our team highly recommends Plus CBD Daily Balance Gummies for anyone steering clear of THC—on to the review!

Check Price

Plus CBD Daily Balance Gummies

Description

Made with CO2-extracted and lab-tested hemp, these gummies ride the industry’s highest standards of quality and safety.

Our testers found them to be effective for stress and discomfort, lasting several hours after use.

Unlike many hemp gummies, these are made with real cane sugar and no artificial flavoring, sweeteners, gluten, or GMO ingredients.

Pros & Cons

Let’s start with the pros:

• Good potency at 25mg/gummy
• Vegan, non-GMO, clean ingredients
• Third-party tested

And now for the cons:

• No THC results in less potent effects
• No secondary cannabinoids detected on lab report

Quality

As we expand on in our Plus CBD Oil review, quality is a key focus throughout all aspects of the brand, from packaging to testing and certification.

Speaking of, Plus CBD oil provides QR codes on their containers—including their THC-free gummies—linking to third-party lab reports. 

They were the first company to receive self-affirmed GRAS (generally recognized as safe) status, an FDA-ready designation that is difficult and expensive to attain. 

The hemp is extracted using CO2, the industry gold standard, and Plus CBD offers full-spectrum as well as THC-free products.

Another thing that differentiates Plus CBD is their sourcing location, Holland.

Holland has very high safety and quality standards in agriculture, including sustainability, allowing Plus CBD to use non-GMO, EU-certified hemp seeds.

You get the point—Plus CBD is a “real one,” as the kids say. Now to the THC-Free gummies review.

Concentration

We sampled the 60-count order of THC-Free Daily Balance CBD Gummies from Plus CBD, which are linked to this certificate of analysis from the third-party lab. 

According to the label, there are 25 milligrams of CBD per gummy, and of course, no THC. 

According to the lab report, there are 29.82 mg of CBD per gummy, but all supporting cannabinoids (CBG, CBN, etc.) are reported as below the limit of quantitation, which is to say, negligibly small amounts. This includes delta-9 THC.

The CBD is clearly over-delivered by a decent, but not problematic amount, and though it’s great to see confirmation that the delta-9 THC amount is basically zero, we would like to see some supporting cannabinoids.

That said, if you’re looking to clearly gauge and/or benefit from the effects of CBD alone with next to zero cross-contamination from other cannabinoids, this is a clean and potent option.

Value

One-time purchasers of Plus CBD Daily Balance THC-Free Gummies will pay $54.99, which reduces to about 3.6 cents per milligram of CBD. 

Typically more expensive on a per-milligram basis than CBD oil tinctures, CBD gummies from reputable brands usually cost somewhere between $0.07-0.11 per milligram. 

However, most of the products we’ve reviewed in this price range are full-spectrum, so that makes this favorable comparison a bit less extreme. 

Still, given Plus CBD’s reputation and this product’s quality, this is definitely one of the best deals we’ve seen for THC-free CBD gummies.

Not to mention, subscribers save a generous 25% (we usually see 10-15%) regularly on this product, dropping the total and per-milligram prices down to $41.24 and 2.7 cents, respectively.

Packaging

As pictured, Plus CBD’s Daily Balance gummies come in a darkly tinted, plastic container with a threaded lid. 

Neither the container nor the lid gave us any difficulties throughout our use of the product, and the labeling provided the following information:

• Key product specs (ingredients, supplement facts, etc.)
• “Free statements” (e.g., no artificial flavoring, artificial sweeteners, gluten, soy, or GMO ingredients)
• Informational blurbs on the brand and the product
• Usage instructions and FDA disclaimer 
• QR code for third-party lab reports

Check Price

Plus CBD Daily Balance Gummies

Description

Made with CO2-extracted and lab-tested hemp, these gummies ride the industry’s highest standards of quality and safety.

Our testers found them to be effective for stress and discomfort, lasting several hours after use.

Unlike many hemp gummies, these are made with real cane sugar and no artificial flavoring, sweeteners, gluten, or GMO ingredients.

As you can see, all the basic info consumers need is readily available, and the informational blurbs as well as the QR code add a layer of authority and transparency.

Overall, the packaging was consistent with other industry-leading brands we’ve reviewed.

Ingredients

In the case of oil tinctures, the vast majority of brands can mix a full-spectrum hemp extract with a carrier oil and call it a day, but the gummy category offers an excellent opportunity for high-quality brands to branch off from the rest.

This is because many brands will use artificial sweeteners, colors, and so on in their CBD gummies.

Such is definitely not the case with Plus CBD Daily Balance Gummies, which contain the following ingredients:

• Cannabidiol (CBD) (From Hemp Extract [Aerial Plant Parts])
• Organic Cane Sugar
• Organic Tapioca Syrup
• Purified Water
• Citrus Pectin
• Citric Acid
• Natural Flavor
• MCT Oil
• Sodium Citrate
• Lycopene (color)

No corn syrup, no sketchy preservatives or coloring, and importantly, Plus CBD keeps it to a reasonable 2 grams of added sugar per gummy.

This is about as clean as a gummy gets, especially when considering they’re made with non-GMO ingredients.

Flavor

These gummies are only available in Wild Berry flavor, which we found to be sweet enough, but not too sweet, and tasty.

They didn’t have that artificial, syrupy taste like cheap candy, but on the other hand, the flavor didn’t cover up that hemp aftertaste very effectively.

If you don’t mind a bit of earthiness, you’ll probably find these gummies as tasty as we did.

Effectiveness

As seasoned reviewers who have tested products with as much as 5 mg of THC per serving, we tempered our expectations in this case because this gummy contains no THC.

As expected, we felt a subtle calming effect and an improvement in mood, but not that strong, total-body relaxation effect associated with THC.

Still, 25 mg of CBD per gummy certainly helped (we popped 2-3 at a time) to relieve sources of mild discomfort and improve stress and mood for several hours.

Whether you’re sensitive to THC or you simply have strong results with CBD, we found this gummy to be among the most effective THC-free products for stress and discomfort.

Key Takeaways

Plus CBD sticks to their staunch standards of product quality and safety in the case of these third-party tested, non-GMO, and vegan CBD gummies.

The lab-confirmed CBD concentration exceeded the label claim for our product batch, though there were no secondary cannabinoids (CBG, CBN) detected.

For a trusted brand, these gummies are a highly competitive value, whether you subscribe or not.

Finally, our team found these gummies to be moderately effective for stress and discomfort.

If you’re staying away from THC for whatever reason and you prefer the fun and familiar approach of gummies, our team highly recommends Plus CBD Daily Balance gummies.

via The CBD Insider https://thecbdinsider.com/review/pluscbd-thc-free-gummies-review/#utm_source=rss&utm_medium=rss&utm_campaign=pluscbd-thc-free-gummies-review

source https://renzverspaget.weebly.com/blog/pluscbd-thc-free-gummies-review

More Regions in Germany Request Cannabis Legalization

TESTSTSARDSAR

More Regions in Germany Request Cannabis Legalization by Johnny Green

A little over a week ago federal ministers in Germany held a press conference in which they provided details regarding the nation’s current legalization plan.

The plan has two phases, with the first involving legalizing personal cannabis possession, use, and cultivation, as well as permitting noncommercial cannabis clubs.

The second phase of legalization in Germany will involve the launch of localized adult-use cannabis commerce pilot projects, sometimes also referred to as ‘model region’ projects.

Join Our Mailing List

The projects will allow localities to launch regional, regulated cannabis sales in Germany for regulatory research and public policy development purposes.

While much is yet to be determined regarding what exact regulations will be involved, there are some components that are out to the public now after the April 12th press conference, and at least two jurisdictions in Germany are already declaring their intent to pursue pilot projects.

FRANKFURT AND OFFENBACH

This week, mere days after the historic press conference in Germany, policymakers in Frankfurt and Offenbach both indicated publicly that their jurisdictions will pursue legal localized cannabis sales as a means to combat the unregulated market.

“If the consumer is no longer stigmatized and criminalized, the discussions about risks can be conducted in a completely different way,” stated Artur Schroers, Head of the Drugs Department of the City of Frankfurt, according to Frankfurter Allgemeine.

Both Frankfurt and Offenbach reportedly issued declarations of intent to pursue the pilot programs.

However, both jurisdictions will need to wait until a legalization measure is formally introduced and adopted, and comprehensive information becomes available regarding how jurisdictions can apply and what requirements will be involved.

EUROPEAN UNION LOBBYING WILL CONTINUE

Multiple lawmakers in Germany are calling for the immediate introduction and implementation of the adult-use legalization plan presented at the press conference earlier this month, and for there to be no further delays in doing so.

_{The projects will allow localities to launch regional, regulated cannabis sales in Germany for regulatory research and public policy development purposes.}

Germany’s Health Minister Karl Lauterbach continues to serve as a political pinball of sorts, bouncing between working with domestic lawmakers at home and lobbying the European Union in an effort to get the EU’s permission for Germany to pursue wider reforms.

The lobbying effort essentially serves as a third phase for German legalization, albeit on a separate path and timeline compared to the first two phases.

This article first appeared on Internationalcbc.com and is syndicated here with special permission.

A link to your site, with your site's name and description as anchor text.

Via https://cannatechtoday.com/more-regions-in-germany-request-cannabis-legalization/

source https://renzverspaget.weebly.com/blog/more-regions-in-germany-request-cannabis-legalization

Chronic Pain Patients Report Improvements in New UK Study

TESTSTSARDSAR

Chronic Pain Patients Report Improvements in New UK Study by Frank Schuler

A fairly sizable study was recently concluded in the United Kingdom involving cannabis, chronic pain, quality of life, and opioid use.

The study revolved around multiple cannabis products, which is not always the case with cannabis studies.

Below is more information about the scope of the study, and the findings, via a news release from NORML:

London, United Kingdom: Chronic pain patients who use cannabis products for six months report improvements in their health-related quality of life and decreases in their daily opioid consumption, according to observational data published in the journal Expert Review of Neurotherapeutics.

Join Our Mailing List

British investigators assessed the safety and efficacy of plant-derived cannabis products (either oils, flower, or a combination of both) in over 700 chronic pain patients enrolled in the UK Medical Cannabis Registry.

All of the participants possessed a doctor’s authorization to access cannabis products. (Since 2018, specialists have been permitted to prescribe cannabis-based medicinal products to patients unresponsive to conventional medications.) 

Authors assessed the efficacy of cannabis at one, three, and six months.

Consistent with prior studies, investigators reported: “Treatment with oil-based [products], dried flowers, or a combination of both CBMPs [cannabis-based medicinal products] are associated with statistically significant improvements in pain relief and sleep quality after six months in chronic pain patients.

“Additionally, patients prescribed oils or both types of CBMPs experienced reduced anxiety and an improvement in their ability to perform daily activities.

_{Prior studies assessing the use of cannabis products in patients enrolled in the UK registry have similarly reported them to be safe and effective for patients suffering from anxiety, post-traumatic stress, depression, migraine, inflammatory bowel disease, and other afflictions.}

“Patients prescribed a combination of both CBMPs recorded improvements in their self-care and mobility abilities. Collectively, this evidence signals that [the] initiation of CBMP treatment is associated with improved HRQoL [health-related quality of life].”

Researchers also acknowledged that patients significantly reduced their daily intake of prescription opioids – a finding that is consistent with dozens of other studies.

“In summary, these results suggest that both [cannabis] oils and dried flowers are associated with long-term improved HRQoL in chronic pain patients,” they concluded.

Prior studies assessing the use of cannabis products in patients enrolled in the UK registry have similarly reported them to be safe and effective for patients suffering from anxiety, post-traumatic stress, depression, migraine, inflammatory bowel disease, and other afflictions.

Data published earlier this year in the journal JAMA Network Open reported that nearly one in four pain patients who reside in states where medical cannabis access is legal self-identify as marijuana consumers.

Full text of the study, “Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK medical cannabis registry,” appears in Expert Review of Neurotherapeutics. Additional information on cannabis and pain management is available from NORML’s publication, Clinical Applications for Cannabis and Cannabinoids.

This article first appeared on Internationalcbc.com and is syndicated here with special permission.

A link to your site, with your site's name and description as anchor text.

Via https://cannatechtoday.com/chronic-pain-patients-report-improvements-in-new-uk-study/

source https://renzverspaget.weebly.com/blog/chronic-pain-patients-report-improvements-in-new-uk-study

Toast to 420 With These Uplifting Cannabis Drinks

TESTSTSARDSAR

Toast to 420 With These Uplifting Cannabis Drinks by David Wallach

Why not celebrate this 420 with a tasty cannabis-infused drink or cannadrink?

Drinkables are abundant for just about every taste, from MXXN infused Tequila to Malus Granny Smith OG Apple Juice.

Cannabis-infused drinks may seem like a relatively new fad, the first cannadrink was actually enjoyed as early as 1000 B.C. in Southern Asia for medicinal, therapeutic, and spiritual purposes.

These days, it’s hard to walk into a dispensary without seeing several options available in a variety of flavors and potencies.

Join Our Mailing List

We put together a list of some cannadrinks for the cannaisseur to make your 420 tasty.

I know, I thought I had one more “canna” pun in there but I canna ran out (see what I did there?).

Lagunitas Hi-Fi Sessions

What happens when Lagunitas, craft-brew icons, and AbsoluteXtracts get together?

The next best thing to happen to weed and hops: Hi-Fi Sessions.

It’s a sparkling hop water with zero alcohol that’s infused with water-soluble THC from the finest California-grown cannabis.

_{It’s a sparkling hop water with zero alcohol that’s infused with water-soluble THC from the finest California-grown cannabis.}

You get all of the fruity and tropical notes from the hops, but without all the other things that can weigh you down.

TeaPot Good Day Iced Tea

For our friends in Canada celebrating, grab yourself a TeaPot and enjoy. 

Brewed by the folks at Sam Adams, TeaPot is only available in Canada (for now). Think Twisted Tea with 5mg of THC.

_{For our friends in Canada celebrating, grab yourself a TeaPot and enjoy.} 

The cultivar from which it’s derived, Pedro’s Sweet Sativa, is grown exclusively in Canada.

TeaPot blended THC with real black tea for this flavor.

Other flavors are reportedly releasing soon.

Good Day Iced Tea is non-carbonated and crafted to minimize any cannabis taste and aroma.

LEVIA Terpene Infused Pineapple Express Seltzer

Pineapple Express will be hitting store shelves this week, just in time to celebrate 420 (available in Massachusetts).

For this limited-edition release, LEVIA is paying homage to one of the world’s most famous strains, Pineapple Express.

The new flavor is LEVIA’s first-ever terpene-infused beverage.

The addition of terpenes brings out the fragrant, fruity flavors of this iconic strain, with familiar earthy notes of pine and cedar alongside signature notes of pineapple and bright citrus.

CANTRIP Root Beer and Orange Soda

Haven’t tried it, but can’t wait. Can you imagine a root beer float with Cantrip? Next level. 

Cantrip has five different flavors with different doses, from 3mg up to 50mg.

Whether you’re new to the weed experience or a cannabis connoisseur, Cantrip has a tasty option for just about everyone.

ALT Premium Liquid Cannabis

ALT comes in two strengths with 5 or 10 milligrams of THC per vial.

ALT THC is a highly adaptable, zero calorie, zero sugar, flavor neutral enhancement that can be added to any just about beverage.

Instead of “wake and bake” on 420, you can wake and pour and sip your special coffee as you begin the day. 

Since ALT is flavorless, you can get creative with which of your favorite beverages you want to mix with ALT: beer, wine, iced tea, drink it as a shot? Your call.

ALT incorporates nanotechnology so that your body absorbs the cannabis particles faster, so there is really no lag time with the ALT experience.

Malus Granny Smith OG Apple Juice

From our friends at Harmony Craft Beverages, THC infused Apple Juice! Why not?

It tastes great, it’s refreshing and Malus is the first beverage to use cannabis live resin!

_{From our friends at Harmony Craft Beverages, THC infused Apple Juice! Why not?}

Imagine your favorite hard cider. Now remove the alcohol and some sugar and carbs.

Lose the hangover and lift your mind, body, and spirit with Malus!

Cheers!

A link to your site, with your site's name and description as anchor text.

Via https://cannatechtoday.com/toast-to-420-with-these-uplifting-cannabis-drinks/

source https://renzverspaget.weebly.com/blog/toast-to-420-with-these-uplifting-cannabis-drinks

Fun Flavorful Cannabis Edibles Youll Love for 420

TESTSTSARDSAR

Fun, Flavorful Cannabis Edibles You’ll Love for 420 by Ebby Stone

It’s the best time of year for cannabis enthusiasts. Dispensaries are stocked up for 420, discounts and sales are abundant, and home cultivators are sewing seeds for fall.

If you’re looking for the latest cannabis products to enjoy on this special holiday, Cannabis & Tech Today has you covered.

In part one of our three-part 420 series, we’re highlighting the tastiest treats to elevate your mood and put the “spring” into your springtime.

Check out these edible offerings and tell us which are your favorites.

Fusion Dissolvable Powder by Matter

Each unflavored packet contains 10mg of non-fizzy THC powder formulated with Quick+ technology.

The tech uses a water-soluble vitamin E derivative to amplify the rate, extent, and duration of cannabinoid absorption.

This newly launched dissolvable from PharmaCann is now available in Illinois and will roll out across additional states soon.

It allows users to turn any food or beverage into an edible that activates in minutes. 

_{This newly launched dissolvable from PharmaCann is now available in Illinois and will roll out across additional states soon.}

Happi Beverages

Most people are familiar with the concept of drinking an alcoholic beverage during a social event. But, have you tried a non-alcoholic cannabis beverage?

Happi’s infused beverages are vegan, gluten free, and all natural.

Happi Glow is formulated to stimulate relaxation.

_{Happi’s infused beverages are vegan, gluten free, and all natural.}

Nightcap is made to help you unwind and get ready for bed.

Its Lemon Elderflower or Raspberry Honeysuckle options are a refreshing option for any after-work social event.

Each variety has its own blend of cannabinoids to pair with your mood. 

Zen Cannabis ‘The Big Zen’

Infused chocolate bars are available on most dispensary shelves, but the Big Zen isn’t your average chocolate bar.

This 420 pound confection is packed with more than 100 pounds of cannabis flower.

This massive nine-foot by four-foot candy bar is powerfully potent, with over 4,200,000mg of THC.

_{This 420 pound edible confection is packed with more than 100 pounds of cannabis flower.}

For just $42,000 you could own this record setting megabar.

For those seeking a slightly more affordable option, Zen offers products ranging from $6-60 in Oklahoma, California, Missouri, and Massachusetts.

Grön Mega Pearl

Sour, sweet, and potently packed with 100mg of THC, the Mega Pearl is perfect for the experienced cannaseur.

It’s made with real fruit and full-spectrum cannabis so you’ll enjoy both the flavor and the effects.

_{Mega Pearls are available in eight flavors: blackberry, sour apple, lemonade, blue razzleberry, passion orange guava, cherry limeade, piña colada, and strawberry habanero.}

Mega Pearls are available in eight flavors: blackberry, sour apple, lemonade, blue razzleberry, passion orange guava, cherry limeade, piña colada, and strawberry habanero.

Pearls are available in Oregon, Nevada, Arizona, Oklahoma, Missouri, and Canada.

Betty’s Eddies

Looking for help drifting off to sleep? Maybe you’re plagued by aches and pains — or perhaps like so many Americans, stress has you on the brink of collapse.

Betty’s has an edible for whatever ails you.

Now with several formulations, three of which are profiled below, Betty’s Eddies are designed with unique blends of cannabinoids to offer targeted relief where you need it.

Take It Easy Eddies, for stress relief, contain 5 mg of THC and CBG paired with 2.5mg of CBDV encapsulated in a pineapple orange fruit chew.

Ache Away Eddies, for pain relief, pair 5mg THC with 20mg CBD and 5mg of CBC to ease inflammation — all in a yummy cherry fruit chew.

_{Ache Away Eddies, for pain relief, pair 5mg THC with 20mg CBD and 5mg of CBC to ease inflammation — all in a yummy cherry fruit chew.}

Bedtime Betty’s are raspberry creme flavored and feature 5mg THC, 10mg CBD, and 5mg CBN to help you drift off into sleepy town.

Plus, they’re all organic, vegan, and gluten free. 

Vibrations Energizing Cannabis Drink Mix

Infuse your day with natural caffeine from guarana paired with full-spectrum cannabis in Vibations unique beverage powder.

This “high-drating” blend is packed with vitamins and electrolytes to keep you going when your energy starts dragging.

_{Infuse your day with natural caffeine from guarana paired with full-spectrum cannabis in Vibations unique beverage powder.}

Vibrations is now available in four flavors: strawberry lemonade, peach tangerine tea, pomegranate blueberry acai, and iced tea lemonade.

These radically refreshing drink-mixes are available in Delaware, Maryland, Massachusetts, and Puerto Rico. 

A link to your site, with your site's name and description as anchor text.

Via https://cannatechtoday.com/fun-flavorful-cannabis-edibles-youll-love-for-420/

source https://renzverspaget.weebly.com/blog/fun-flavorful-cannabis-edibles-youll-love-for-420

High-Quality Pre-Rolls: Is Robotics Part of the Secret Sauce?

TESTSTSARDSAR

High-Quality Pre-Rolls: Is Robotics Part of the Secret Sauce?  by Nohtal Partansky

Across the U.S., pre-rolls are rising in sales and popularity among cannabis consumers. The convenience of pre-rolls allows consumers to avoid the work of rolling their own, a preference that ranks high with the market’s target audience. 

But as much as pre-rolls are gaining market share, not all things are looking up for this product category. The products themselves are just as quickly gaining a reputation for hit-or-miss quality and a lack of overall consistency. 

Join Our Mailing List

This poses a problem for industry operators — one that robotics could potentially solve. 

The Current State of Pre-Rolls

There’s no question about it: Pre-rolls are gaining traction in sales. Headset, a cannabis analytics company, recently reported that pre-roll sales increased 38.9% from 2020 to 2022.

Another report shows that in California, the number of online carts that only have pre-rolls went from 47% to 53% in just one year. 

_{The Sorting Robotics team creates pre-roll automation technology such as the Jiko pre-roll robot.}

But that’s not all. Infused pre-rolls are having a moment, too. Coinciding with the trend toward desiring convenience is a heightened demand for potency.

To keep up with the trends, brands are now infusing pre-rolls with cannabis oil or concentrate to boost potency and meet these unique customer needs.

Senior data analysts at Headset called infused pre-rolls the “segment to watch in 2022,” considering the category took over as the second-largest, with sales doubling in both years. 

Infusing pre-rolls adds a whole new element for operators to manage in producing a uniform product that delivers a consistent experience for consumers.

Lacking consistency is one of the fastest ways to self-sabotage a brand. To avoid doing so, facilities are increasingly turning to technology to automate, fine-tune, and elevate the way pre-rolls are made.

Implementing Robotics to Improve Quality 

The perfect pre-roll is an art form, as simple as it may appear.

The flower has to have just the right consistency and be packed just the right way to deliver the smooth, even burn that consumers crave.

_{With the right equipment, brands can calculate exact ratios and fine-tune mechanisms to produce the perfect pre-roll with every fill.}

Today, pre-roll manufacturers are finding it incredibly difficult to achieve this type of precision and accuracy. 

That’s where robotics and automation technology enter the conversation.

With the right equipment, brands can calculate exact ratios and fine-tune mechanisms to produce the perfect pre-roll with every fill.

Want More Like This? Read the latest issue of Cannabis & Tech Today.

This not only allows pre-roll manufacturers to automate and scale processes to increase their bottom line, but it improves the end-consumer experience too. 

Most operators struggling to make a profit and keep staff might think this type of technology is out of reach. But even though it might take a genius to design and engineer robotics-powered pre-roll infusion technology, it doesn’t take a genius to use the finished product.

It’s not necessary to hire new teams to operate automated systems, which is another benefit of implementing automation technology to improve consistency and quality. 

The Future of High-Tech-Powered Pre-Rolls

As the industry evolves, so will product quality and the advanced processes it takes to deliver pre-rolls people can depend upon.

We’ve seen concentrate quality improve over the years, solventless goods take over the game, and now it’s time for pre-rolls to evolve to meet market demand.

So don’t give up on pre-rolls just yet and stay tuned as brands transform from hit-or-miss to tech-powered quality. 

This article first appeared in Volume 4 Issue 4 of Cannabis & Tech Today. Read the full issue here.

A link to your site, with your site's name and description as anchor text.

Via https://cannatechtoday.com/high-quality-pre-rolls-is-robotics-part-of-the-secret-sauce/

source https://renzverspaget.weebly.com/blog/high-quality-pre-rolls-is-robotics-part-of-the-secret-sauce

Cannabis Use is Segmenting. So Are the Investment Opportunities.

TESTSTSARDSAR

Cannabis Use is Segmenting. So Are the Investment Opportunities. by Deena Vallina

Although wellness is not a new concept, a global pandemic helped bring it once again to the forefront. Not only are more consumers interested in wellness, but they are now viewing it through a wider and more sophisticated lens.

It is no longer just about fitness and nutrition, but also overall physical and mental health. There are a wider variety of products available and customers are demanding clean, natural, products designed to improve health and well-being. 

So, what does this have to do with cannabis? Everything! As perceptions change and social stigmas across age groups relax, a new sector is emerging. Somewhere between strict, medical-only use, and solely recreational use, is wellness.

Join Our Mailing List

We’re finding the cannabis industry targeting the self-care and wellness-minded consumer. This lucrative subsection of the billion-dollar cannabis industry will be instrumental in achieving mainstream acceptance of the plant.

Furthermore, MJBizDaily noted these wellness products have a greater appeal to those that intend to, but currently do not use cannabis.

Whether treating a specific medical condition, relaxing, creating mindfulness, exercising, substituting for other (less healthy) activities, or utilizing it as a beauty regimen, individuals are using cannabis for a variety of reasons and redefining wellness.

Many products that fall under the wellness label are categorized as medical. As this suggests, medical cannabis is splitting into two separate markets, medicinal to treat specific ailments, and wellness products for health and overall well-being.

Executives believe there is money to be made by capitalizing on both.

Medical

In 2021, 42% of cannabis users identified as medical consumers and 95% believed their conditions had improved with cannabis, with 56% reporting significant improvement.

The top five medical considerations consumers bought cannabis to treat were anxiety (41%), arthritis (29%), pain (29%), insomnia (18%), and migraines (17%).

Hundreds of millions of Americans experience each of these conditions; 20 million+ anxiety, 51 million+ arthritis, and 140 million+ pain, and many of them will consider trying it — particularly if existing consumers overwhelmingly report improvement. 

Wellness

Wellness products for overall well-being, not specifically used for treating a certain condition, can be further delineated into subcategories such as relaxation and mental health, fitness, substitution, and cosmetics.

Consumer data from a research study conducted by New Frontier Data found nearly 23% of current cannabis consumers use cannabis to improve their overall health and wellness.

Wellness-specific uses for cannabis rank highest for relaxation (67%), stress relief (62%), reducing anxiety (54%), improving sleep quality (46%), and pain management (45%).

While many wellness uses are similar to medical uses, the key difference is that wellness consumers use cannabis for overall mental and physical well-being and support as opposed to use for specific conditions.

Men and women both report relaxation and stress relief as their leading reasons for cannabis use. 

Fitness

The stereotype of the unhealthy, sedentary stoner is no longer accurate. A study using 10 years of data collected by the National Health and Nutrition Examination Survey (NHANES) found that any lifetime cannabis use was associated with higher odds of physical activity.

New Frontier Data reports that age is a factor when considering cannabis use as it relates to exercise. Those under 45 had a higher percentage of reported use of cannabis with exercise than those over 45, with the highest (13%), among consumers aged 35-44.

Substitution

Wellness-minded consumers are also replacing alcohol with cannabis as more than 81% of current users believe that cannabis is safer than alcohol.

While only 16% of consumers specifically list replacing alcohol as their reason for using cannabis, New Frontier Data reported 47% have replaced at least some of their alcohol use with cannabis.

Prescription medications are also being replaced for many users. Emerging research indicates that the increased use of cannabis as medicine has had a substitution effect on prescription drug use.

Want More Like This? Read the latest issue of Cannabis & Tech Today.

Several cross-sectional surveys report substituting cannabis for prescription drugs, of which opioids, antidepressants, and anti-anxiety drugs are the most prevalent.

The substitution of prescription drugs is the most common motive among users of medical cannabis, surpassing substitution rates for alcohol and illicit drugs. 

Moreover, state medical cannabis laws in the United States have been associated with a sizeable reduction in prescription drugs, particularly opioid prescriptions, and with fewer prescription opioid-related hospitalizations, lower rates of opioid overdoses, and decreases in opioid-related healthcare costs.

Health and Beauty

Medicinal qualities in cannabis have created a demand for infused health and beauty products.

Antimicrobials, antioxidants, and other therapeutic properties contained in these skin care products are responsible for this segment’s growth, with the United States accounting for or 47% of the $5.45 billion global market, and women comprising two-thirds of consumers.

An estimated compound annual growth rate of 5.5% will increase the total market value to $10.9 billion by 2030, reported Global Newswire.

_{An estimated compound annual growth rate of 5.5% will increase the total market value to $10.9 billion by 2030, reported Global Newswire.}

When you consider global wellness market values at US$4.5 trillion in 2022 and projected to increase by 2%-4% annually, and global cannabinoid market values at at US$27.7 billion with an annual projected growth rate of 25%, and by offering wellness products in subcategories that are already popular in the hemp-derived CBD market, estimated to reach $16B by 2025, there is an abundant future for wellness products in the cannabis space.

The aforementioned data was reported by the Global Wellness Institute, BDS Analytics, and Cowen Research, respectively.

At these cross-sections lies a unique opportunity for brands to develop specific effect-based products to capture their piece of the proverbial pie.

This article first appeared in Volume 4 Issue 4 of Cannabis & Tech Today. Read the full issue here.

A link to your site, with your site's name and description as anchor text.

Via https://cannatechtoday.com/cannabis-use-is-segmenting-so-are-the-investment-opportunities/

source https://renzverspaget.weebly.com/blog/cannabis-use-is-segmenting-so-are-the-investment-opportunities

Delta-9 vs Delta-8 THC: Whats the Difference?

It’s amazing how an extra atom here or a spun-around molecule there can significantly alter the way a compound interacts with the body, but such is life—literally. 

The many similarities and differences between delta-8 and delta-9 THC provide a fitting example of this effect, though this beautifully nuanced chemistry is often lost in the politicized debate these compounds find themselves constantly embroiled in. 

If you’re not wearing a lab coat, don’t worry—here’s a plain-speak explanation of the similarities and differences between delta-8 and delta-9 THC.

First things first, we can’t compare and contrast these cannabinoids if we don’t know what they are (or what the heck a “cannabinoid” is).

The Differences Between Delta-8 and Delta-9

Delta-9 and delta-8 THC (tetrahydrocannabinol) are psychoactive compounds native to cannabis plants, referred to along with 100+ other cannabis-based compounds as “cannabinoids.”

Psychoactive, by the way, refers to a substance or drug that can cause changes in your mood state or other key brain states/functions.

Alongside CBD (cannabidiol), delta-9 THC is one of the most abundant cannabinoids in cannabis plants, where delta-8 is usually found in considerably smaller quantities.

You can breed hemp plants to select for higher amounts of “naturally occuring” delta-8 THC, but it’s very unlikely you’ll reach a product-grade concentration without synthesizing the compound from other cannabinoids.

The chemical formula for both delta-8 and delta-9 THC is the same: C₂₁H₃₀O_2. 

As mentioned, subtle differences in how these atoms interact with each other gives each form of THC its unique differences.

In this case, delta-9 THC has a double bond between two carbon atoms that starts on the ninth carbon, where delta-8 has the same bond starting on the 8th carbon atom. 

And, well, that’s it. This molecular difference between delta-9 and delta-8 alone gives each molecule unique attributes, though there is still a whole lot of overlap. 

Delta-8 vs Delta-9 THC: Potency, Benefits, and More

The potency difference is easy to remember because it mirrors the natural abundance of these two compounds: delta-8 THC is considerably less potent than delta-9 THC. 

That said, “potency” is a bit of a blanket term that sometimes forces apples and oranges into the same blender, so it’s important to know exactly what functions and/or medical benefits we’re seeing between delta-8 and delta-9 THC.

Benefits of Delta-8 and Delta-9 THC

Though more delta-8 THC research is definitely needed, this information sheet by PubChem identifies these benefits:

• Nausea and vomiting relief
• Stress relief
• Increased appetite
• Analgesic effects (pain)
• Potential to protect nerve tissue

Delta-9 THC has also been associated with stress relief, improved appetite, and nausea control, though there are plenty of clinically significant differences in how it interacts with the body. Here are some examples:

• Euphoria, improved mood state
• Improved sensory perception
• Enhanced creativity
• Improved libido

As for what cannabis users subjectively report, the majority agree that delta-8 THC is milder, making it (reportedly) less likely to cause paranoia, increased anxiety, or an intense high that interferes with basic tasks.

Legality

Finally, it’s time to address the elephant in the room: the legal situation.

However contentious delta-9 THC (and cannabis in general) may still be, it’s a hot button that we’ve all had our thumbs on since before the 1930s, whereas the popularizing of delta-8 THC products was very much a sudden shock.

Hence, states across the country have reacted to delta-8 THC differently, many severely restricting the manner in which it is (synthetically) produced, while others take a more passive stance as they closely monitor the cannabinoid.

The FDA and CDC issued warnings to the public about Delta-8 THC in late 2021, and a couple months later, the DEA confirmed it is not a controlled substance.

In other words, delta-8 THC is still a bit polarizing, and several states have cracked down on it significantly, but you can still find plenty of delta-8 THC products online. Just, you know—don’t necessarily buy them at a gas station. 

Summary

Summarizing our breakdown of the delta-8 and delta-9 THC comparison are these major points:

Slightly Different Molecules: Both cannabinoids share the chemical formula C₂₁H₃₀0_2, but they differ on where a particular double bond is placed.

Potency and Benefits: Delta-8 THC is less potent than delta-9, and while the two share many benefits, you can consult the section above to see their differences.

Legality: “Hey, first time?” Says delta-9 to delta-8 THC as it is ping-ponged about by continually shifting guidelines. Where and how these cannabinoids are restricted does vary, but the fact that they’re constantly being debated and legislated for or against is very much a commonality.

Delta-9 Versus Delta-8 THC FAQ

Does Delta 9 get you higher than delta-8?

Generally, yes. 

Concentration, concurring medications, the form of the product, and other factors can considerably affect how potent each cannabinoid is, but if you take them both in the same circumstances, delta-9 causes a stronger high. 

What is better for sleep, Delta-8 or Delta 9?

The most reliable answer is that we aren’t completely sure yet. 

Though delta-9 THC is more potent, and can produce a calming effect just like delta-8 THC, some delta-8 users swear by this cannabinoid as the more effective aid.

We need to hold out for more cannabis research on this one.

Is Delta 9 natural or synthetic?

Delta-9 is a naturally occurring constituent of the cannabis plant. However, synthetic forms of delta-9 THC do exist. 

Will Delta-8 show up on a drug test?

Wouldn’t you know, we have an entire article dedicated to this question. Spoiler alert: yes.

Key Takeaways

Delta-8 and delta-9 THC are psychoactive cannabinoids found in hemp plants that differ very slightly in their molecular structure.

Delta-8 is found in much smaller quantities in hemp plants, where as delta-9 THC is more abundant, similar to CBD.

Many of the effects of these compounds overlap, but they are also different in their potency (delta-8 elicits a milder high) and benefits to a degree.

You can buy both delta-8 and delta-9 THC products online, but check your local laws before purchasing either at a brick-and-mortar retail outlet. 

via The CBD Insider https://thecbdinsider.com/knowledge-center/delta-9-vs-delta-8/#utm_source=rss&utm_medium=rss&utm_campaign=delta-9-vs-delta-8

source https://renzverspaget.weebly.com/blog/delta-9-vs-delta-8-thc-whats-the-difference